It has also been demonstrated in a randomized, placebo-controlled, double-blind study that LG improved glucose metabolism and cognition in AD patients (76)
DJANG: It doesnt seem to really be significant
10.1002/jbmr.2564 Summary Keywords glucagonlike peptide1 receptor agonist, randomized controlled trial, older adults, bone mineral density, bone turnover Citation Dinkla L, Beavers KM, Robbins R, Akpalu D, Wherry SJ, Miller G, Beavers DP, Espinoza S, Trejo J, Stepanenko A and Cortes TM (2025) Bone mineral density and turnover response to GLP-1 receptor agonists in older adults with overweight/obesity and prediabetes/type 2 diabetes: a 20-week pilot trial post hoc analysis
Track: Weekly weight (same day, same time, same conditions) Measurements (waist, hips, chestmore reliable than scale alone) Side effects (what you feel, when, how severe) Food intake (even rough estimates help) PeptIQ makes this simplelog doses, track inventory, monitor your response over time